SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 34 filers reported holding SEELOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $27,994 | -40.4% | 40,500 | -11.0% | 0.02% | -21.4% |
| Q3 2022 | $47,000 | +193.8% | 45,500 | +97.8% | 0.03% | +180.0% |
| Q2 2022 | $16,000 | 0.0% | 23,000 | +130.0% | 0.01% | +25.0% |
| Q4 2021 | $16,000 | -83.2% | 10,000 | -74.7% | 0.01% | -83.3% |
| Q3 2021 | $95,000 | +33.8% | 39,500 | +46.3% | 0.05% | +17.1% |
| Q2 2021 | $71,000 | -64.5% | 27,000 | -32.5% | 0.04% | -52.3% |
| Q1 2021 | $200,000 | +53.8% | 40,000 | -50.4% | 0.09% | +17.8% |
| Q4 2020 | $130,000 | – | 80,687 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,500,000 | $4,075,000 | 1.71% |
| Connacht Asset Management LP | 498,925 | $813,000 | 0.79% |
| GENDELL JEFFREY L | 2,449,267 | $3,992,000 | 0.32% |
| MANGROVE PARTNERS IM, LLC | 2,133,436 | $3,478,000 | 0.21% |
| Uniplan Investment Counsel, Inc. | 1,550,359 | $2,527,000 | 0.14% |
| Financial Advocates Investment Management | 24,673 | $1,994,000 | 0.13% |
| Connacht Asset Management LP | 72,300 | $118,000 | 0.12% |
| Woodline Partners LP | 4,047,231 | $6,597,000 | 0.09% |
| 1492 Capital Management LLC | 108,286 | $177,000 | 0.09% |
| Ikarian Capital, LLC | 244,171 | $398,000 | 0.06% |